| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.00037 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0004 | 1 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.00031 | 1 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.00052 | 1 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.00051 | 1 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.0003 | 1 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.00023 | 1 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.00032 | 1 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.0002 | 1 |